Diarrhoea in the ICU: respective contribution of feeding and antibiotics

Critical Care

Claude Pichard²  Claudia Paula Heidegger¹  Nathalie Delieuvin¹  Aurélie Clerc²  Séverine Graf²  Ronan Thibault² 

[1] Division of Intensive Care, Rue Gabrielle-Perret-Gentil 4, 1211 Geneva University Hospital, Geneva, Switzerland;Nutrition Unit, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, Geneva 14 1211, Switzerland

关键词: Nursing care;    Clostridium difficile;    Antifungal drugs;    Liquid stools;    Tube feeding;   

Others  :  817995
DOI  :  10.1186/cc12832

 received in 2013-03-18, accepted in 2013-07-09,  发布年份 2013

【 摘 要 】

Introduction

Diarrhoea is frequently reported in the ICU. Little is known about diarrhoea incidence and the role of the different risk factors alone or in combination. This prospective observational study aims at determining diarrhoea incidence and risk factors in the first 2 weeks of ICU stay, focusing on the respective contribution of feeding, antibiotics, and antifungal drugs.

Methods

Out of 422 patients consecutively admitted into a mixed medical–surgical ICU during a 2-month period, 278 patients were included according to the following criteria: ICU stay >24 hours, no admission diagnosis of gastrointestinal bleeding, and absence of enterostomy or colostomy. Diarrhoea was defined as at least three liquid stools per day. Diarrhoea episodes occurring during the first day in the ICU, related to the use of laxative drugs or Clostridium difficile infection, were not analysed. Multivariate and stratified analyses were performed to determine diarrhoea risk factors, and the impact of the combination of enteral nutrition (EN) with antibiotics or antifungal drugs.

Results

A total of 1,595 patient-days were analysed. Diarrhoea was observed in 38 patients (14%) and on 83 patient-days (incidence rate: 5.2 per 100 patient-days). The median day of diarrhoea onset was the sixth day, and 89% of patients had ≤4 diarrhoea days. The incidence of C. difficile infection was 0.7%. Diarrhoea risk factors were EN covering >60% of energy target (relative risk = 1.75 (1.02 to 3.01)), antibiotics (relative risk = 3.64 (1.26 to 10.51)) and antifungal drugs (relative risk = 2.79 (1.16 to 6.70)). EN delivery per se was not a diarrhoea risk factor. In patients receiving >60% of energy target by EN, diarrhoea risk was increased by the presence of antibiotics (relative risk = 4.8 (2.1 to 13.7)) or antifungal drugs (relative risk = 5.0 (2.8 to 8.7)).

Conclusion

Diarrhoea incidence during the first 2 weeks in a mixed population of patients in a tertiary ICU is 14%. Diarrhoea risk factors are EN covering >60% of energy target, use of antibiotics, and use of antifungal drugs. The combination of EN covering >60% of energy target with antibiotics or antifungal drugs increases the incidence of diarrhoea.

【 授权许可】

   
2013 Thibault et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]World Health Organisation: The Treatment of Diarrhoea. A Manual of Physicians and Other Senior Health Workers. Geneva: World Health Organisation; 1990.
• [2]Ferrie S, East V: Managing diarrhoea in intensive care. Aust Crit Care 2007, 20:7-13.
• [3]Jack L, Coyer F, Courtney M, Venkatesh B: Diarrhoea risk factors in enterally tube fed critically ill patients: a retrospective audit. Intensive Crit Care Nurs 2010, 26:327-334.
• [4]Kelly T, Patrick M, Hillman K: Study of diarrhoea in critically ill patients. Crit Care Med 1983, 11:7-9.
• [5]Reintam A, Parm P, Kitus R, Kern H, Starkopf J: Gastrointestinal symptoms in intensive care patients. Acta Anaesthesiol Scand 2009, 53:318-324.
• [6]Smith CE, Marien L, Brogdon C, Faust-Wilson P, Lohr G, Gerald KB, Pingleton S: Diarrhea associated with tube feeding in mechanically ventilated critically ill patients. Nurs Res 1990, 39:148-152.
• [7]McClave SA, Sexton LK, Spain DA, Adams JL, Owens NA, Sullins MB, Blandford BS, Snider HL: Enteral tube feeding in the intensive care unit: factors impeding adequate delivery. Crit Care Med 1999, 27:1252-1256.
• [8]Montejo JC: Enteral nutrition-related gastrointestinal complications in critically ill patients: a multicenter study. The nutritional and metabolic working group of the Spanish society of intensive care medicine and coronary units. Crit Care Med 1999, 27:1447-1453.
• [9]Whelan K, Schneider SM: Mechanisms, prevention, and management of diarrhea in enteral nutrition. Curr Opin Gastroenterol 2011, 27:152-159.
• [10]Wiesen P, Van Gossum A, Preiser JC: Diarrhoea in the critically ill. Curr Opin Crit Care 2006, 12:149-154.
• [11]Kreymann KG, Berger MM, Deutz NE, Hiesmayr M, Jolliet P, Kazandjiev G, Nitenberg G, van den Berghe G, Wernerman J, Ebner C, Hartl W, Heymann C, Spies C, German Society for Nutritional Medicine: ESPEN guidelines on enteral nutrition: intensive care. Clin Nutr 2006, 25:210-223.
• [12]Homann HH, Kemen M, Fuessenich C, Senkal M, Zumtobel V: Reduction in diarrhea incidence by soluble fiber in patients receiving total or supplemental enteral nutrition. JPEN J Parenter Enteral Nutr 1994, 18:486-490.
• [13]Rushdi TA, Pichard C, Khater YH: Control of diarrhea by fiber-enriched diet in ICU patients on enteral nutrition: a prospective randomized controlled trial. Clin Nutr 2004, 23:1344-1352.
• [14]Yang G, Wu XT, Zhou Y, Wang YL: Application of dietary fiber in clinical enteral nutrition: a meta-analysis of randomized controlled trials. World J Gastroenterol 2005, 11:3935-3938.
• [15]Alberda C, Gramlich L, Jones N, Jeejeebhoy K, Day A, Dhaliwal R, Heyland D: The relationship between nutritional intake and clinical outcomes in critically ill patients: results of an international multicenter observational study. Intensive Care Med 2009, 35:1728-1737.
• [16]Dossett LA, Redhage LA, Sawyer RG, May AK: Revisiting the validity of APACHE II in the trauma ICU: improved risk stratification in critically injured adults. Injury 2009, 40:993-998.
• [17]Frohmader TJ, Chaboyer WP, Robertson IK, Gowardman J: Decrease in frequency of liquid stool in enterally fed critically ill patients given the multispecies probiotic VSL#3: a pilot trial. Am J Crit Care 2010, 19:e1-e11.
• [18]Heidegger CP, Berger MM, Graf S, Zingg W, Darmon P, Costanza MC, Thibault R, Pichard C: Optimisation of energy provision with supplemental parenteral nutrition in critically ill patients: a randomised controlled clinical trial. Lancet 2013, 381:385-393.
• [19]Zeger SL, Liang KY: Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986, 42:121-130.
• [20]Pan W: Akaike’s information criterion in generalized estimating equations. Biometrics 2001, 57:120-125.
• [21]Kuritz SJ, Landis JR, Koch GG: A general overview of Mantel–Haenszel methods: applications and recent developments. Annu Rev Public Health 1988, 9:123-160.
• [22]Bleichner G, Blehaut H, Mentec H, Moyse D: Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial. Intensive Care Med 1997, 23:517-523.
• [23]Bliss DZ, Johnson S, Savik K, Clabots CR, Willard K, Gerding DN: Acquisition of clostridium difficile and clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding. Ann Intern Med 1998, 129:1012-1019.
• [24]Grube B, Heimbach C, Marvin J: Clostridium difficile diarrhea in critically ill burned patients. Arch Surg 1987, 122:655-666.
• [25]Zar FA, Bakkanagari SR, Moorthi KM, Davis MB: A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007, 45:302-307.
• [26]Nguyen NQ, Ching K, Fraser RJ, Chapman MJ, Holloway RH: Risk of Clostridium difficile diarrhoea in critically ill patients treated with erythromycin-based prokinetic therapy for feed intolerance. Intensive Care Med 2008, 34:169-173.
• [27]Artinian V, Krayem H, Digiovine B: Effects of early enteral feeding on the outcome of critically ill mechanically ventilated medical patients. Chest 2006, 129:960-967.
• [28]Pichard C, Schwarz G, Frei A, Kyle U, Jolliet P, Morel P, Romand JA, Sierro C: Economic investigation of the use of three-compartment total parenteral nutrition bag: prospective randomized unblinded controlled study. Clin Nutr 2000, 19:245-251.
• [29]Luft VC, Beghetto MG, de Mello ED, Polanczyk CA: Role of enteral nutrition in the incidence of diarrhea among hospitalized adult patients. Nutrition 2008, 24:528-535.
• [30]Gramlich L, Kichian K, Pinilla J, Rodych NJ, Dhaliwal R, Heyland DK: Does enteral nutrition compared to parenteral nutrition result in better outcomes in critically ill adult patients? A systematic review of the literature. Nutrition 2004, 20:843-848.
• [31]Genton L, Dupertuis YM, Romand JA, Simonet ML, Jolliet P, Huber O, Kudsk KA, Pichard C: Higher calorie prescription improves nutrient delivery during the first 5 days of enteral nutrition. Clin Nutr 2004, 23:307-315.
• [32]Martins JR, Shiroma GM, Horie LM, Logullo L, Silva Mde L, Waitzberg DL: Factors leading to discrepancies between prescription and intake of enteral nutrition therapy in hospitalized patients. Nutrition 2012, 28:864-867.
• [33]Villet S, Chiolero RL, Bollmann MD, Revelly JP, Cayeux RNM, Delarue J, Berger MM: Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients. Clin Nutr 2005, 24:502-509.
• [34]Keller BP, Wille J, van Ramshorst B, van der Werken C: Pressure ulcers in intensive care patients: a review of risks and prevention. Intensive Care Med 2002, 28:1379-1388.